Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop

被引:0
|
作者
Emma L Arriola
Ana Rodriguez Lopez
Christine M Chresta
机构
[1] CRC Molecular and Cellular Pharmacology Research Group,
[2] School of Biological Sciences,undefined
[3] The University of Manchester,undefined
来源
Oncogene | 1999年 / 18卷
关键词
testicular neoplasms; p53; Mdm2; etoposide; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
The Mdm2 protein is frequently overexpressed in human non-seminomatous germ cell tumours and transitional carcinoma of the bladder where it may contribute to tolerance of wtp53. Mdm2 forms an autoregulatory feedback loop with p53; the Mdm2 gene is responsive to transactivation by p53 and once synthesized the Mdm2 protein terminates the p53 response. We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis. Cytotoxic concentrations of etoposide (IC90 for >3 h) result in inhibition of Mdm2 induction at both the RNA and protein level. Rapid apoptosis ensues. Global transcription is not inhibited: p21waf-1/cip-1 and GADD45 expression increase in a dose dependent manner. Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription. Downregulation of Mdm2 transcript occurs in cells expressing HPV16-E6 suggesting that inhibition of Mdm2 transcription is p53-independent. When cells are treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated. Induction of apoptosis and loss of clonogenicity are 3 – 5-fold lower under pulse treatment conditions. This is the first observation of inhibition of Mdm2 transcription following treatment with topoisomerase (topo II) poisons, a feature that may be useful in tumour types where p53 is tolerated by overexpression of Mdm2.
引用
收藏
页码:1081 / 1091
页数:10
相关论文
共 50 条
  • [31] Potential Landscape and Flux of p53-Mdm2 Oscillator Mediated by Mdm2 Degradation Rate
    Bi, Yuanhong
    Yang, Zhuoqin
    INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS, 2016, 26 (03):
  • [32] Global dynamics and stability of p53-Mdm2 oscillator mediated by Mdm2 production rate
    Bi Yuan-Hong
    Yang Zhuo-Qin
    He Xiao-Yan
    ACTA PHYSICA SINICA, 2016, 65 (02)
  • [33] p21(WAF1/CIP1) and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: A p53+, MDM2-, p21- immunophenotype associated with missense p53 mutations
    Villuendas, R
    Pezzella, F
    Gatter, K
    Algara, P
    SanchezBeato, M
    Martinez, P
    Martinez, JC
    Munoz, K
    Garcia, P
    Sanchez, L
    Kocialkowsky, S
    Campo, E
    Orradre, JL
    Piris, MA
    JOURNAL OF PATHOLOGY, 1997, 181 (01): : 51 - 61
  • [34] Co-expression of p21WAF1/CIP1, p53, pRb, mdm2 and cyclin D1 in NSCLC cells
    Dworakowska, D
    Jassem, E
    Jassem, J
    Wiedorn, K
    Boltze, C
    Dworakowski, R
    Lapinski, M
    Tomaszewski, D
    Jaskiewucz, K
    Czestochowska, E
    LUNG CANCER, 2005, 49 : S290 - S291
  • [35] Gambogic acid down-regulates MDM2 oncogene and induces p21Waf1/CIP1 expression independent of p53
    Rong, Jing-Jing
    Hu, Rong
    Qi, Qi
    Gu, Hong-Yan
    Zhao, Qing
    Wang, Jia
    Mu, Rong
    You, Qj-Dong
    Guo, Qing-Long
    CANCER LETTERS, 2009, 284 (01) : 102 - 112
  • [36] MDM2、p53和p21WAF1/CIP1蛋白在胃癌中的表达及意义
    浣孝强
    孟斌
    邓卓霖
    缪勇建
    广西医科大学学报, 2002, (01) : 35 - 38
  • [37] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    NATURE, 1997, 387 (6630) : 299 - 303
  • [38] p53, mdm-2, and p21 waf-1 in the porokeratoses
    Nelson, C
    Cowper, S
    Morgan, M
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1999, 21 (05) : 420 - 425
  • [39] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    Nature, 1997, 387 : 299 - 303
  • [40] Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the p53-MDM2 pathway
    Hu, M
    Gu, LC
    Li, MY
    Jeffrey, PD
    Gu, W
    Shi, YG
    PLOS BIOLOGY, 2006, 4 (02) : 228 - 239